BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to U-251 cell line is 41
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 1 | 34424812 |
| CD44 | 1681 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR and FACs | NA | 0.48 | 1 | 33575080 |
| CD44 | 1681 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by IF staining and SFA | NA | 0.48 | 1 | 19324493 |
| HMGA1 | 5010 | LTM | Glioblastoma | NA | U-251 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.0042 | 21300033 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 34424812 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | FACs followed by SFA and SP assay and IHC staining | NA | 0.48 | 0.7582 | 19232461 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | SFA and MACs and qRT-PCR | NA | 0.48 | 0.7582 | 28881826 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | BIX01294 | SFA and Western Blotting | NA | 0.48 | 0.7582 | 24833465 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | SFA and Western Blotting | NA | 0.48 | 0.7582 | 28394339 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by IF staining and SFA | NA | 0.48 | 0.7582 | 19324493 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | Suspended cell culturing and SFA followed by IF staining | NA | 0.48 | 0.7582 | 23258424 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.7582 | 31288857 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by FACs | NA | 0.48 | 0.7582 | 33575080 |
| PROM1 | 9454 | LTM | Glioblastoma | NA | U-251 | NA | FACs followed by SFA | NA | 0.48 | 0.7582 | 21300033 |
| SOX2 | 11195 | LTM | Glioblastoma | NA | U-251 | BIX01294 | SFA and Western Blotting | NA | 0.28 | 0.5695 | 24833465 |
| SOX2 | 11195 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 33575080 |
| SOX2 | 11195 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.5695 | 31288857 |
| SOX2 | 11195 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 19324493 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by IHC staining | NA | 0.24 | 0.0573 | 19232461 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by IF staining and SFA | NA | 0.24 | 0.0573 | 19324493 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | IF staining followed by SFA | NA | 0.24 | 0.0573 | 26170223 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | Suspended cell culturing and SFA followed by IF staining | NA | 0.24 | 0.0573 | 23258424 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.24 | 0.0573 | 33575080 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by RT-PCR | NA | 0.24 | 0.0573 | 31288857 |
| NES | 7756 | LTM | Glioblastoma | NA | U-251 | NA | SFA and qRT-PCR | NA | 0.24 | 0.0573 | 28881826 |
| ABCG2 | 74 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1739 | 19232461 |
| BMI1 | 1066 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1135 | 19232461 |
| BMI1 | 1066 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by qRT-PCR | NA | 0.2 | 0.1135 | 19324493 |
| CTNNB1 | 2514 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0647 | 19232461 |
| GLI1 | 4317 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0308 | 19232461 |
| KLF4 | 6348 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0891 | 33575080 |
| MSI1 | 7330 | LTM | Glioblastoma | NA | U-251 | NA | CFA followed by qRT-PCR | NA | 0.2 | 0.0201 | 19324493 |
| MYC | 7553 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1304 | 33575080 |
| NANOG | 20857 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 33575080 |
| NANOG | 20857 | LTM | Glioblastoma | NA | U-251 | NA | SFA and qRT-PCR | NA | 0.2 | 0.5461 | 28881826 |
| NOTCH2 | 7882 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0117 | 19232461 |
| POU5F1 | 9221 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 33575080 |
| PTEN | 9588 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0053 | 19232461 |
| MICA | 7090 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by FACs | NA | 0.12 | 0.0021 | 31288857 |
| NAMPT | 30092 | LTM | Glioblastoma | NA | U-251 | NA | SFA and CFA followed by FACs | NA | 0.12 | 0.0032 | 29245920 |
| ULBP2 | 14894 | LTM | Glioblastoma | NA | U-251 | NA | SFA followed by FACs | NA | 0.12 | 0.0021 | 31288857 |